Tucker‑biotech debate video

A Tucker Carlson interview posted April 13 put embryo screening and “baby customization” into a 101-minute prime-time debate with Nucleus Genomics chief executive Kian Sadeghi. (podcasts.apple.com) The basic science starts with in vitro fertilization, which creates multiple embryos in a lab, and genetic testing, which checks those embryos for inherited conditions before one is transferred. Older tests look for single-gene disorders or chromosome problems; newer software tries to rank embryos for future disease risk and traits using many DNA variants at once. (asrm.org) Nucleus markets that newer layer as “genetic optimization” and says its embryo product gives parents information on “long-term health and traits.” The company says Nucleus Preview screens for more than 2,000 hereditary diseases for parents, and its embryo product uses whole-genome data to compare embryos created through in vitro fertilization. (mynucleus.com) In the Tucker episode, Sadeghi was introduced as the founder and chief executive of Nucleus Genomics, a company founded in 2021 that has raised more than $32 million from investors including Founders Fund, Seven Seven Six, and Samsung Next. The episode description said the service lets parents choose traits “from height to IQ to personality traits.” (podcasts.apple.com) Nucleus formally launched Nucleus Embryo in June 2025 and called it “the first genetic optimization software” for embryos. On its site, the company says parents can reduce risk for some diseases by choosing among two to five embryos, and it presents examples for conditions including type 1 diabetes. (mynucleus.com, mynucleus.com) Medical societies have taken a narrower view. In a 2026 ethics opinion, the American Society for Reproductive Medicine said current evidence does not support the predictive accuracy, safety, or clinical value of polygenic embryo screening and said it should not be used for nonmedical trait selection. (asrm.org, asrm.org) European genetics groups raised similar objections earlier. The European Society of Human Genetics said in December 2021 that using polygenic risk scores on embryos was “unproven” and “unethical,” and the European Society of Human Reproduction and Embryology later said it supported that position. (eshg.org, eshre.eu) Sadeghi has argued the opposite in public interviews. On CBS in December 2025, he said parents have a right to select qualities they want in a child, while critics in the same segment said the science remains limited and the social risks are large. (cbsnews.com) The fight is no longer staying inside fertility clinics or bioethics journals. By mid-April 2026, the Carlson interview had turned a specialized dispute over embryo ranking, disease prediction, and trait selection into a mass-audience argument about medicine, religion, and the limits of parental choice. (tuckercarlson.com, youtube.com)